Sarcoma Arising in Oligodendroglioma of the Brain

Feigin, Irwin; Ransohoff, Joseph; Lieberman, Abraham

doi:10.1097/00005072-197611000-00005

Cited by 74 publications

(83 citation statements)

References 0 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…The gliomatous tissue also has highly cellular areas, devoid of reticulin or collagen, which contain large pleomorphic, poorly differentiated, anaplastic glial cells. These special characters are completely the same as those of sarcoma arising in glioblastoma of the brain reported by Feigin and Gross (1955).…”

Section: Comments and Discussionsupporting

confidence: 75%

The Sarcoma Arising in Giloblastoma: Clinico-pathological Report of Two Cases

Takata

Richardson

1975

Tohoku J. Exp. Med.

View full text Add to dashboard Cite

Section: Comments and Discussionsupporting

confidence: 75%

The Sarcoma Arising in Giloblastoma: Clinico-pathological Report of Two Cases

Takata

Richardson

1975

Tohoku J. Exp. Med.

View full text Add to dashboard Cite

“…1,[18][19][20][21][22][23][24][25][26][27][28][29][30] Given the relative rarity of PGS, these reports support the clinical experience that PGS may have a greater potential for metastasis than GBM. However, in our series of 20 consecutive patients, there were no documented cases of metastases.…”

Section: Figurementioning

confidence: 72%

“…It was originally described by Stroebe in 1895, and gained wide acceptance after detailed histologic descriptions by Feigin et al 1,2 In 2000, PGS was classified by the World Health Organization (WHO) grading scheme as a variant of glioblastoma multiforme (GBM). 3 The current accepted definition in the 2007 WHO classification of PGS is a well-circumscribed lesion with clearly identifiable gliomatous and metaplastic mesenchymal components.…”

mentioning

confidence: 99%

Clinical characteristics and outcomes for a modern series of primary gliosarcoma patients

Han

Yang

Ahn

et al. 2010

Cancer

View full text Add to dashboard Cite

BACKGROUND: Primary gliosarcoma (PGS) is a rare central nervous system tumor with limited experience reported in the literature. In the current study, the authors present a modern series of confirmed PGS cases treated in the era of magnetic resonance imaging (MRI), after the accepted glioblastoma management of resection, radiation, and temozolomide. METHODS: Using a retrospective review, patients with confirmed PGS were identified (1996‐2008). Cases were determined to be PGS by central pathology review using the 2007 World Health Organization criteria. Extensive chart review was performed to gather clinical and pathologic data on these cases. RESULTS: All but 1 patient had undergone a preoperative MRI, with 1 patient receiving a computed tomography scan due to a cardiac pacemaker. A total of 10 patients received radiotherapy with concurrent and adjuvant temozolomide chemotherapy, and 8 patients received radiotherapy alone or in combination with other chemotherapeutic agents. In 2 patients, the history of adjuvant treatment could not be confirmed. The overall median survival was 13.9 months (range, 2.2‐22.9 months). Patients with gliosarcomas resembling meningioma were found to have a significantly prolonged median survival compared with patients harboring gliosarcoma resembling glioblastoma multiforme (16 months vs 9.6 months; P = .011). However, no difference in survival was noted between patients who received concurrent radiotherapy and temozolomide compared with those who did not (10.4 months vs 13.9 months; P = .946). CONCLUSIONS: The results of the current study support previous hypotheses that there are 2 distinct types of PGS. The type mimicking the appearance of a meningioma appears to carry a significantly more favorable prognosis, most likely due to an increased chance at achieving macroscopic total resection. Cancer 2010. © 2010 American Cancer Society.

show abstract

“…[18][19][20] Occasionally, A GS developing superficially in the temporal lobe may extend into the leptomeninges, eliciting a desmoplastic response that produces an encapsulated, firm lesion both radiographically and grossly suggestive of a meningioma (Fig 4). In 1 series, approximately 12% of cerebral GSs presented as dural-based tumors.…”

Section: Gliosarcomasmentioning

confidence: 99%

Dural lesions mimicking meningiomas

et al. 2002

View full text Add to dashboard Cite

Recently, a number of neoplastic and nonneoplastic entities have been reported that radiographically and clinically mimic meningiomas. Because these lesions occur infrequently and may resemble a meningioma during intraoperative analysis, they may not be considered in the differential diagnosis. This review (and case illustrations) considers some of the newly recognized and notable lesions that can mimic meningiomas, including solitary fibrous tumors, gliosarcomas, leiomyosarcomas, hemangiopericytomas, melanocytomas, Hodgkin's disease, plasmacytomas, inflammatory pseudotumors, neurosarcoidosis, plasma cell granulomas, Rosai-Dorfman disease, Castleman's disease, xanthomas, rheumatoid nodules, and tuberculomas. Awareness that these lesions involve the dura may facilitate intraoperative recognition and, in some cases, preclude unnecessary additional surgery. HUM PATHOL 33:1211-1226.

show abstract

Sarcoma Arising in Oligodendroglioma of the Brain

Cited by 74 publications

References 0 publications

The Sarcoma Arising in Giloblastoma: Clinico-pathological Report of Two Cases

The Sarcoma Arising in Giloblastoma: Clinico-pathological Report of Two Cases

Clinical characteristics and outcomes for a modern series of primary gliosarcoma patients

Dural lesions mimicking meningiomas

Contact Info

Product

Resources

About